Global (R)-3-Aminopiperidine Dihydrochloride market was valued at USD 38.6 million in 2025 and is projected to reach USD 74.8 million by 2034, growing at a CAGR of 6.9% during the forecast period. The compound is widely used as a chiral pharmaceutical intermediate in the synthesis of APIs, particularly DPP-4 inhibitors for diabetes treatment, as well as CNS and other therapeutic drugs. Market growth is driven by increasing diabetes prevalence, rising pharmaceutical R&D investments, and growing demand for high-purity enantiopure intermediates in modern drug development.
Get Full Report Here: https://www.24chemicalresearch.com/reports/307576/aminopiperidine-dihydrochloride-market